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Involucrin is one of the precursor proteins of the cornified
cell envelope that is formed beneath the cell membrane
during terminal differentiation of keratinocytes. 12-O-
tetradecanoylphorbol-13-acetate (TPA), which is a potent
protein kinase C (PKC) activator, induces terminal differ-
entiation of keratinocytes. We previously demonstrated
that involucrin promoter activity is stimulated by TPA
in cultured fetal rat skin keratinocytes. PKC is a large
family of proteins and keratinocytes containing five PKC
isozymes: a, δ, e, η, and ζ. In order to determine the
role of the PKC isozyme(s) on involucrin gene expression,
we constructed the chloramphenicol acetyl transferase
(CAT)-involucrin promoter expression vector by con-
necting the 59-upstream region of the human involucrin
gene containing the untranslated first exon to the CAT
reporter gene. The CAT-involucrin promoter expression
vector was transfected with various PKC isozyme expres-
sion vectors into SV40-transformed human keratinocytes
(SVHK cells). Transfection of the CAT-involucrin pro-
moter expression vector with PKC-a or PKC-η expres-
sion vectors resulted in a significant increase in the
TPA-dependent involucrin promoter activity. The PKC
inhibitor, 1-(5-isoquinoline-sulfonyl)-2-methyl piperaz-
ine dihydrochloride, inhibited the promoter activity
stimulated by TPA. Transfection of PKC-δ, -e, and
The cornified cell envelope (CE) is a highly insolublestructure formed beneath the plasma membrane ofkeratinocytes during terminal differentiation (Hohl,1990; Goldsmith, 1993; Eckert et al, 1993). The CEprovides a protective barrier between the environment
and the living layers of the skin, and is believed to play an important
role in maintaining the structural integrity of the epidermis. Transgluta-
minase 1 catalyzes the glutamyl-lysine cross-linking reaction of various
CE precursor proteins that include involucrin (Eckert and Green,
1986), loricrin (Hohl et al, 1991), cystatin A (keratolinin) (Takahashi
et al, 1997), small proline-rich protein(s) (Kartasova and van de Putte,
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-ζ had no effect on the involucrin-promoter activity.
Although the promoter activity was stimulated by trans-
fection of PKC-γ, TPA did not enhance the promoter
activity in the PKC-γ-transfected SVHK cells. Previously
we showed three AP-1 binding sites (AP1–1, –2, and –3)
on the involucrin promoter region. Both the basal and
the TPA-stimulated involucrin promoter activities were
suppressed by deleting the AP1–1 site (–119 to –113)
that is the most proximal to the transcription start site.
The deletion of AP1–2 (–297 to –303) or AP1–3
(–447 to –453) did not affect the involucrin promoter
activity. Gel retardation analyses disclosed that TPA
stimulated the specific DNA binding of the nuclear
protein(s) of control, PKC-a, or PKC-η-transfected
SVHK cells, but not of PKC-γ-transfected cells. Addition
of anti-c-Jun and anti-c-Fos antibodies decreased the
specific protein-DNA complex band with a concomitant
appearance of supershifted bands. These results indicate
that PKC, specifically PKC-a and PKC-η, mediates the
TPA-dependent activation of involucrin gene expression
of SVHK cells. PKC-γ, which is not present in ker-
atinocytes, also induces involucrin gene expression in a
TPA-independent manner, when introduced into SVHK
cells. Key word: cornified cell envelope. J Invest Dermatol
110:218–223, 1998
1988), elafin (Steinert and Marekov, 1995), and envoplakin (Ruhrberg
et al, 1996). Recent evidence suggests that involucrin is an early
component of CE and provides a scaffold onto which several other
precursor proteins are incorporated (Steinert and Marekov, 1995;
Ishida-Yamamoto et al, 1997).
Human involucrin gene contains a 59 exon of 43 bp and a 39 exon
of 2107 bp that are separated by an intron of 1188 bp (Eckert and
Green, 1986). The structure is characterized by a central segment
composed of 39 tandem repeats of 10 amino acids, which is flanked
by N- and C-terminal segments. The repeating structure of the central
portion is highly conserved in all higher primates (Eckert and Green,
1986), suggesting recent evolutionary origin of involucrin. Involucrin
is expressed in the squamous tissue, and is detected in the upper
spinous layer and the granular layer of normal human epidermis (Banks-
Schlegel and Green, 1981).
Although considerable information is available regarding the function
and the evolution of involucrin protein (Eckert et al, 1993), less is
known about the regulation of the involucrin gene expression. Trans-
genic animal studies have shown that 2.5 kb of the 59 upstream
sequence of the involucrin gene is sufficient to confer to differentiation-
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dependent and tissue-specific expression of the involucrin (Crish
et al, 1993, Carrol et al, 1993). 12-O-tetradecanoylphorbol-13-acetate
(TPA), a potent protein kinase C (PKC) activator, induces involucrin
gene expression through a nuclear factor, AP1. The AP1, which is a
complex consisting of jun and fos family proteins, binds to TPA-
responsive elements (TRE) and regulates the TPA-inducible genes.
The promoter of the human involucrin gene has at least five TRE
(Takahashi and Iizuka, 1993; Welter et al, 1995; Lopez-Bayghen et al,
1996). These AP1 binding sites are designated as AP1–1 to AP1–5;
AP1–1 is the most proximal to the transcription start site and AP1–5
is the most distal. We and others have also demonstrated that TEF-1,
POU factors, and YY-1 decrease the transcription of the involucrin gene
(Takahashi et al, 1995; Welter et al, 1996; Lopez-Bayghen et al, 1996).
PKC is a large family of proteins that consists of at least 11 isozymes
(Nishizuka, 1992). PKC-α, -βI, -βII, and -γ are the classical PKC,
which depend on calcium and diacylglycerol. PKC-δ, -ε, -η, -θ, and
-µ are the novel PKC, which do not require calcium for activation.
PKC-ζ and -τ are the atypical PKC, which require neither calcium
nor diacylglycerol for the activation. TPA activates classical and novel
PKC but not atypical PKC. The keratinocytes contain PKC-α, -δ,
-ε, -η, and -ζ (Dlugosz et al, 1992). The specific function of each
PKC isozyme, especially in terms of involucrin gene expression,
remains unknown at present.
SV40-transformed human keratinocytes (SVHK cells) are well-
established immortalized cell lines sharing features of normal human
keratinocytes (Steinberg and Defendi, 1983; Takahashi et al, 1990).
SVHK cells express relatively high amounts of involucrin compared
with other cell lines, such as A431 and SCC13 (data not shown). In
this study, we constructed the CAT-involucrin promoter expression
(INV-CAT) vector, which was subcloned from the 59-upstream region
of the involucrin gene with the untranslated first exon and was
connected to the chloramphenicol acetyl transferase (CAT) reporter
gene. Using the INV-CAT vector, we investigated the effects of PKC
isozymes on the involucrin promoter activity of SVHK cells.
MATERIALS AND METHODS
Plasmids constructs The Sca I-digested fragment from the genomic involuc-
rin gene was inserted into the Xba I site of promoterless 0-CAT plasmid, which
had been blunt-ended by Klenow fragment (INV-CAT) (Takahashi and Iizuka,
1993). The β-galactosidase expression vector was kindly supplied by Dr. T.
Watanabe (Medical Institute of Bioregulation, Kyushu University, Japan). PKC
expression vectors were generous gifts from Dr. S. Ohno (Department of
Molecular Biology, Yokohama City University School of Medicine) (Ohno
et al, 1988). Each deleted fragment was generated by an ‘‘overlap extension’’
method (Ho et al, 1989) using polymerase chain reaction (PCR) using oligo-
nucleotides (DL–1, 59-CTTATGAGCATGGCATTCCTGAGAA-39; DL–2,
59-TTTGAAGATCTTCCCATGAAGGGGT-39; DL–3, 59-TCATGGGAA-
GATCTTCA-39; DL–4, 59-TGTGACCAACTTCTGCTCTG-39; DL–5, 59-
AGCAGAAGTTGGTCACA-39; DL–6, 59-ACCCCTTCCCCACAGGC-
ATC-39; DL–7, 59-TGTCCCTGGACCCTAAAGGGTTTGC; DL–8, 59-
AGGAGTCAGGGCACACTTTATATCA). The positions of these sequences
are indicated in Fig 1. In order to construct the AP1–3 deleted vector (T3),
we performed two PCR amplifications using DL–1 and DL–2 oligomers or
DL–3 and DL–8 oligomers using the INV-CAT vector as the template. Next
we performed a PCR procedure using DL–1 and DL–8 oligomers using mixed
PCR product derived from DL–1 and DL–2 oligomers or DL–3 and DL–8
oligomers. The second PCR product, which contained two Pst I sites (Fig 1,
double underline), was digested by Pst I restriction enzyme and was subcloned
into the Pst I sites of the deleted INV-CAT vector, which was deleted at the
position of the Pst I sites. Using DL–1 and DL–8 oligomers, we performed
sequence analysis and confirmed the correct promoter orientation and the
deleted portion. AP1–2-deleted (T2) and AP1–1-deleted (T1) vectors were
constructed using DL–1, DL–4, DL–5, and DL–8 oligomers, and DL–1,
DL–6, DL–7, and DL–8 oligomers, respectively. Using T1, T2, and T3 vectors,
we performed PCR with these oligomers and constructed T12 (AP1–1,
–2-deleted), T13 (AP1–1, –3-deleted), T23 (AP1–2, –3-deleted), and T123
(AP1–1, –2, –3-deleted) vectors.
Cell culture SV40-transformed human keratinocytes were a generous gift
from Dr. M.L. Steinberg (Department of Chemistry, City College of the City
University of New York) (Steinberg and Defendi, 1983). Cells were cultured
in Dulbecco’s modified Eagle’s medium supplemented with 5% fetal calf serum,
100 u penicillin per ml, and 100 µg streptomycin per ml at 37°C in 5% CO2
in air.
Figure 1 Four AP1 sites are present on the 59-upstream region of the
human involucrin gene. DL–1–8 indicate the positions of the primers.
Double underlining indicates the positions of the restriction enzyme, Pst I. The
bold letter A is the transcriptional start site. The four shaded boxes indicate
putative TRE sites, which are designated as AP1–1 to AP1–4.
Transfection and CAT assay Transfection of plasmid DNA into these cells
was performed by the liposome method using lipofectin (Felgner et al, 1987).
Typically, 5 µg of reporter plasmid and 2 µg of β-galactosidase plasmid were
transfected into 1 3 105 SVHK cells. The β-galactosidase plasmid was used as
the internal standard to normalize each transfection efficacy. After 48 h, cells
were collected and CAT assay was performed (Neuman et al, 1987). The
enzyme activity of β-galactosidase in the transfected cell extracts was measured
spectrophotometrically (Maniatis et al, 1989).
PKC enzyme assay PKC enzyme assay was performed using the protein
kinase C enzyme assay kit (Amersham Japan, Tokyo, Japan). Briefly, 1 3 106
transfected SVHK cells were homogenized in the extraction buffer [50 mM Tris-
HCl (pH 7.5), 5 mM ethylenediamine tetraacetic acid, 10 mM ethyleneglycol-
bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid, 0.3% (wt/vol) β-mercapto-
ethanol, 10 mM benzamidine, 50 µg phenylmethylsulfonyl flouride per ml].
The homogenates were centrifuged and the supernatants were assayed according
to the protocol equipped with the assay kit.
Nuclear extraction and gel retardation analyses Nuclear extraction and
gel retardation analyses were performed according to the method previously
described (Takahashi et al, 1995). The oligonucleotide probe corresponds to
–125 to –104, which includes the AP1–1 site.
Materials Dulbecco’s modified Eagle’s medium was purchased from Gibco
(Grand Island, NY). Penicillin and streptomycin were obtained from M.A.
Bioproducts (Walkersville, MD). [3H]-Acetyl coenzyme A, [γ-32P]ATP, and
[α-32P]deoxycytidine thiotriphosphate were purchased from Amersham (Tokyo,
Japan). Lipofectin was obtained from BRL (Bethesda, MD). Anti-c-jun,
-junB, -junD, -c-fos, -NFκB, and -fra–1 antibodies were purchased from Santa
Cruz Biotechnology (Santa Crus, CA). Various isozyme-specific anti-protein
kinase C antibodies were purchased from Beohringer (Penzberg, Germany).
RESULTS
Transfection of PKC isozyme expression vectors increased PKC
activity in SVHK cells We transfected various PKC isozyme
expression vectors into SVHK cells. The increased expression of PKC-
α was confirmed by immunoblot analysis and was shown to be plasmid
dose-dependent (Fig 2). These effects were detected by the transfection
of other PKC expression vectors (data not shown). The PKC expression
vector-transfected SVHK cells showed increased PKC activity by
around 2-fold compared with the activity of SVHK cells without
the transfection (Table I). TPA stimulated the PKC activity of the
transfected SVHK cells by around 6-fold, except for PKC-ζ-transfected
SVHK cells (Table I).
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Figure 2 PKC-α was expressed in SVHK cells in a concentration-
dependent manner by the transfection. One 3 105 SVHK cells were
transfected with various amounts (0–3 µg) of PKC-α expression vector.
Transfected cells were incubated for 48 h and western blot analysis was
performed.
Figure 3 Transfection of PKC-a or PKC-η expression vectors increased
involucrin promoter activity of TPA-treated SVHK cells. Various PKC
isozyme expression vectors (5 µg each) were transfected into 1 3 105 SVHK
cells with INV-CAT vector (5 µg), and the transfected cells were incubated for
24 h. The transfected cells were then cultured in the presence or absence of
TPA (10 ng per ml) for 24 h. The CAT activity of SVHK cells transfected with
INV-CAT alone without TPA stimulation was designated as 1.0. C, control
vector; α, PKC-α; β, PKC-β; δ, PKC-δ; ε, PKC-ε; γ, PKC-γ; ζ, PKC-ζ; η,
PKC-η.
Table I. Effects of PKC expression vector on PKC enzyme
activity of SVHK cells
Expression vector PKC enzyme activity (pmoles per min per mg)a
Medium TPA
control vector 58.6 6 13.1 150.3 6 14.5
PKC-α 115.5 6 22.3 698.8 6 26.7
PKC-β 106.5 6 20.3 647.8 6 29.4
PKC-γ 125.3 6 19.2 678.3 6 19.6
PKC-δ 111.6 6 17.5 688.2 6 26.9
PKC-ε 121.1 6 15.2 700.9 6 30.2
PKC-ζ 109.8 6 21.1 199.4 6 28.3
PKC-η 105.9 6 23.5 630.4 6 32.1
aResults are the means 6 SEM.
Transfection of PKC-a or PKC-η expression vectors increased
involucrin promoter activity in TPA-treated SVHK cells To
determine the role of PKC isozymes on involucrin gene expression,
we performed co-transfection of the INV-CAT vector with various
PKC isozyme expression vectors (Fig 3). Consistent with TPA-induced
activation of endogenous PKC, involucrin promoter activity was
increased by TPA in SVHK cells transfected with control vector (Fig 3,
lane C). Transfection of PKC-β, -δ, -ε, -ζ had no effect on the
involucrin promoter activity compared with the transfection of the
control vector. Although the transfection of these vectors also increased
the promoter activity in the presence of TPA, the augmentation was
not significantly different from that of the control vector-transfected
cells (Fig 3, lanes β, δ, ε, ζ). Involucrin promoter activity, however,
Figure 4 Increased promoter activity by the transfection of PKC
expression vector was suppressed by PKC inhibitor H-7. Following co-
transfection of INV-CAT vector and PKC isozyme (α, γ, η) expression vectors,
SVHK cells were incubated with TPA (10 ng per ml) or H-7 (100 µM), or
both, for 24 h. The CAT activity of cells transfected with INV-CAT alone
without TPA stimulation was designated as 1.0.
was significantly stimulated by the co-transfection of PKC-α or PKC-
η in a TPA-dependent manner (Fig 3, lanes α, η). The promoter
activity was stimulated by the transfection of PKC-γ in the absence of
TPA (Fig 3, lane γ). TPA did not augment the promoter activity of
PKC-γ-transfected SVHK cells. The PKC inhibitor, 1-(5-isoquinoline-
sulfonyl)-2-methyl piperazine dihydrochloride (H-7), significantly
inhibited the promoter activity stimulated by TPA in control, PKC-
α, and -η expression vector-transfected SVHK cells (Fig 4). The
addition of H-7 singly to the incubation medium significantly inhibited
the promoter activity of PKC-γ-transfected SVHK cells, but had no
effect on other PKC vector-transfected SVHK cells (Fig 4). These
results indicate that the activation of PKC-α and -η results in stimulation
of involucrin promoter activity and that PKC-γ introduced into SVHK
cells is endogenously activated in the absence of TPA.
AP1–1 site (–119 to –113) was critical for involucrin promoter
activity The 59-upstream promoter region of the INV-CAT vector
contains three AP-1 binding sequences (AP1–1, –2, and –3) (Fig 1).
In order to determine the critical TRE region(s) in the INV-CAT
vector, we constructed various TRE-deleted vectors. The transfection
of AP1–2- or AP1–3-deleted vectors had no effect on the involucrin
promoter activity that was stimulated by TPA. The transfection of
AP1–1 deleted vectors (T1, T12, T13, T123), however, showed a
significant decrease in the basal involucrin promoter activity and TPA-
dependent stimulation was abolished (Fig 5). In addition, involucrin
expression was not stimulated by TPA in PKC-α- or PKC-η-transfected
SVHK cells, when AP1–1 was deleted from the INV-CAT vector
(Fig 6); the deletion of AP1–2 or –3 again had no effect. The putative
AP1–4 (–512 to –505), which is also present in our INV-CAT vector
(Welter et al, 1995), was apparently not functional, because our deletion
analysis showed negligible effect on the promoter activity (Figs 5, 6).
This is consistent with the results of Welter et al (1995), indicating that
within the promoter region up until –811 bp, the AP1–1 region is
critical for the regulation of the basal and PKC-stimulated involucrin
promoter activity in SVHK cells.
Nuclear factor(s) from PKC-a and -η-transfected SVHK cells
specifically bound to the AP1–1 site that is stimulated by
TPA The interaction between the AP1–1 sequence and the AP-1
nuclear protein(s) was investigated by gel shift analyses (Fig 7A).
Control-vector-transfected SVHK cells showed a specific band indicat-
ing the interaction of nuclear protein with AP1–1 consensus sequence,
which was stimulated by the addition of TPA. The nuclear factor(s)
from PKC-α- and -η-transfected SVHK cells showed a significantly
increased binding to the probe, which was efficiently competed by the
excess of unlabeled oligomers containing the AP1–1 binding site. As
expected, PKC-γ-transfected SVHK cells did not show TPA-dependent
stimulation of the specific DNA-protein binding. Anti-c-jun and anti-
VOL. 110, NO. 3 MARCH 1998 REGULATION OF INVOLUCRIN GENE BY PKC 221
Figure 5 AP1–1 site (–119 to –113) was critical for involucrin promoter
activity. Each TRE deleted INV-CAT vector was transfected into SVHK cells,
and the cells were treated with TPA (10 ng per ml) for 24 h. The activity of
cells transfected with INV-CAT alone without TPA stimulation was designated
as 1.0. C, INV-CAT vector; T3, AP1–3-deleted INV-CAT vector; T2, AP1–
2-deleted INV-CAT vector; T1, AP1–1-deleted INV-CAT vector; T23, AP1–
2 and –3-deleted INV-CAT vector; T13, AP1–1- and –3-deleted INV-CAT
vector; T12, AP1–1- and –2-deleted INV-CAT vector; T123, AP1–1-, –2-,
and –3-deleted INV-CAT vector.
Figure 6 The transfection of PKC-a or PKC-η expression vectors
stimulated AP1–1 containing INV-CAT promoter activity. Following
co-transfection of TRE-deleted INV-CAT vectors with PKC-α (A) or PKC-
η (B) expression vectors, SVHK cells were incubated with or without TPA
(10 ng per ml) for 24 h. The activity of cells transfected with INV-CAT alone
without TPA stimulation was designated as 1.0. C, INV-CAT vector; T3, AP1–
3-deleted INV-CAT vector; T2, AP1–2-deleted INV-CAT vector; T1, AP1–
1-deleted INV-CAT vector; T23, AP1–2- and –3-deleted INV-CAT vector;
T13, AP1–1- and –3-deleted INV-CAT vector; T12, AP1–1- and –2-deleted
INV-CAT vector; T123, AP1–1-, –2-, and –3-deleted INV-CAT vector.
c-fos antibody decreased the specific bands, and a supershifted band
appeared near the top of the lane (Fig 7B, lanes 4 and 6). No
supershifted band was detected by the addition of anti-junB, -junD,
or -fra-1 antibodies (Fig 7B, lanes 5, 7, and 8). These results indicate
that TPA stimulates the binding of nuclear factor(s) from PKC-α- and
-η-transfected SVHK cells to the AP1–1 site, and the nuclear factor is
most likely composed of c-jun and c-fos.
Figure 7 Nuclear factor(s), which are composed of c-jun and c-fos
protein, from PKC-a and -η-transfected SVHK cells specifically bound
to AP1–1 site in the presence of TPA. (A) The nuclear extracts (4 µl) from
PKC-transfected SVHK cells were reacted with the synthesized oligomer, which
contained AP1–1 region. The DNA-protein complex was separated on 4%
polyacrylamide gel. C, nuclear extract from control vector transfected SVHK
cells; α, nuclear extract from PKC-α expression vector transfected-SVHK cells;
η, nuclear extract from PKC-η expression vector transfected-SVHK cells; γ,
nuclear extract from PKC-γ expression vector transfected-SVHK cells. The
concentration of TPA was 10 ng per ml. Competitor indicate 50 3 unlabeled
probe. (B) Lane 1, nuclear extract from TPA-treated SVHK cells; lane 2, nuclear
extract from TPA-treated SVHK cells plus 50 3 unlabeled probe; lane 3, nuclear
extract from TPA-treated SVHK cells plus the oligomer containing AP-2
consensus sequence; lane 4, nuclear extract from TPA-treated SVHK cells plus
anti-c-jun antibody; lane 5, nuclear extract from TPA-treated SVHK cells plus
anti-junB antibody; lane 6, nuclear extract from TPA-treated SVHK cells plus
anti-c-fos antibody; lane 7, nuclear extract from TPA-treated SVHK cells plus
anti-junD antibody; lane 8, nuclear extract from TPA-treated SVHK cells plus
anti-fra-1 antibody; lane 9, nuclear extract from TPA-treated SVHK cells plus
anti-NFκB antibody. The → indicates the supershift band.
DISCUSSION
Involucrin with an extended rod-shaped structure (Yaffe et al, 1992) is
assumed to be initially incorporated into CE, forming a scaffold onto
which other CE precursors, such as elafin, SPRR, and loricrin, are
deposited (Steinert, 1995; Steinert and Marekov, 1995). The involucrin
gene expression is tissue-specific and differentiation-dependent and
normally detected in the suprabasal epidermal layers (Eckert, 1989).
Although SVHK cells make up a transformed cell line, they are much
more easily manipulated in transfection experiments of involucrin gene
expression. Notably SVHK cells contain similar PKC isozymes (α, δ,
ε, η, ζ) as normal human keratinocytes and show a significant involucrin
expression, which is marginally detected in A431 and SCC13 cells
(data not shown).
Involucrin gene is TPA-inducible and contains several AP-1 binding
sites on the 59-upstream of the promoter region (Takahashi and Iizuka,
1993; Welter et al, 1995; Lopez-Bayghen et al, 1996). Our results
indicate that PKC-α and PKC-η, when introduced into SVHK
cells, mediate the TPA-dependent activation of the involucrin gene
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transcription. The effect was inhibited by the specific PKC inhibitor,
H-7. Transfection of PKC-γ also stimulated involucrin gene expression
in the absence of TPA. Previous analyses indicate that keratinocytes
contain five PKC isozymes, PKC-α, -δ, -ε, -η, and -ζ (Dlugosz et al,
1992). SVHK cells do not contain PKC-γ (data not shown). So far
PKC-γ is solely expressed in the nervous system, and we suppose that
PKC-α and -η are responsible for the regulation of the involucrin
gene expression of keratinocytes.
There are several reports concerning the localization of PKC
isozymes in the epidermis (Leibersperger et al, 1991; Wever et al, 1992;
Koizumi et al, 1993). In normal skin, PKC-η is expressed in the
uppermost granular layer (Koizumi et al, 1993), whereas PKC-α
mRNA is expressed from basal to spinous layers (Wever et al, 1992).
Because involucrin is expressed in the upper spinous layer and the
granular layer, the involucrin gene might be activated initially by PKC-
α in the spinous layer and then by PKC-η in the granular layer. The
nuclear factors, such as TEF-1, POU, and YY-1, might suppress the
involucrin expression in the basal cell layer (Takahashi et al, 1995;
Welter et al, 1996; Lopez-Bayghen et al, 1996).
Involucrin is known to be cross-linked by transglutaminase 1. Ueda
et al reported that transglutaminase 1 is induced by PKC-η in fetal rat
skin keratinocytes (Ueda et al, 1996). They also showed that the
transcription of transglutaminase 1 was increased by the transfection of
PKC-η expression vector even in the absence of TPA stimulation.
Although we also detected an increase in PKC activity of around 2-
fold in the absence of TPA by the transfection of each PKC expression
vector, the involucrin transcription level did not change in SVHK
cells. Ueda et al used luciferase expression vectors for the reporter
gene, which is known to be more sensitive than the CAT reporter
gene. In addition, the transfection efficacy of the INV-CAT vector
into SVHK cells is much less than that into fetal rat skin keratinocytes
(Takahashi and Iizuka, 1993). These factors might explain the discrep-
ancy of the results of gene expression between the two cell lines in
terms of TPA-dependency.
PKC-γ stimulated the transcription of the involucrin gene in a TPA-
independent manner. It is known that PKC-γ is less sensitive to
diacylglycerol but is markedly stimulated by low concentrations of free
arachidonic acid (Sekiguchi et al, 1988); PKC-α and -β isozymes
require higher concentrations of arachidonic acid for full activation.
The transcriptional activation of INV-CAT by PKC-γ in the absence
of TPA might indicate the increased arachidonic acid level in SVHK
cells. Consistent with the idea that the introduced PKC-γ is endogen-
ously activated in SVHK cells, the effect of PKC-γ was also inhibited
by the protein kinase C inhibitor, H-7.
Co-transfection of various AP-1-deleted expression vectors showed
that AP1–1, which is located on –119 to –113, the most proximal to
the transcription start site, was critical for the TPA-dependent regulation
of involucrin gene transcription. These results are consistent with
previous reports showing that AP1–1 is one of the most active
regulatory domains of the involucrin gene (Takahashi and Iizuka, 1993;
Welter et al, 1995; Lopez-Bayghen et al, 1996). Welter et al showed
that fra-1, junB, and junD are the binding factors for the AP-1 sites
in the involucrin promoter (Welter et al, 1995). In our analysis,
combined c-fos and c-jun overexpression in keratinocytes activated
the involucrin promoter (Takahashi and Iizuka, 1993) and gel shift
analysis indicated that the c-fos/c-jun complex specifically bound to
the AP1–1 sites (Fig 7B). It must be mentioned, however, that AP1–
1 deletion from the INV-CAT vector did not completely suppress the
transcriptional activity, suggesting the presence of other regulatory
factor(s) for the involucrin gene transcription.
TPA-treated epidermis shares features of psoriatic hyperproliferative
epidermis. These include increased involucrin expression (Takahashi
et al, 1996), increased phospholipase A2 (Bartel et al, 1987), phospho-
lipase C (Fisher et al, 1990), and transglutaminase activities (Esmann
et al, 1989). Interestingly, diacylglycerol level in the psoriatic epidermis
is increased compared with the uninvolved or normal epidermis (Fisher
et al, 1990), suggesting that PKC is activated in the psoriatic epidermis.
An apparent decrease in PKC activity (Horn et al, 1987) as well as in
Jun/Fos expression (Basset-Seguin et al, 1991) might reflect downregul-
ation of PKC following its activation; PKC-α is sensitive to downregul-
ation and in situ hybridization analysis indicated decreased expression
of PKC-α in psoriasis (Wever et al, 1992). On the other hand,
the expression of PKC-η, which is insensitive to downregulation
(Murakami et al, 1996), is distributed in the uppermost granular layer
in normal epidermis and suprabasal layers in psoriatic epidermis
(Koizumi et al, 1993). It is interesting to note that the localization of
PKC-η mostly coincides with that of involucrin in the normal and
psoriatic epidermis, suggesting that PKC-η might be responsible for
the involucrin expression.
Besides involucrin, proteins involved in CE formation include
loricrin, cystatin A, SPRR, and transglutaminase 1 (see Introduction),
the expression of which are all stimulated by TPA (Yamanishi et al,
1992; DiSepio et al, 1995; Owens et al, 1996).
This suggests a common controlling mechanism for the expression
of CE precursor proteins as well as cross-linking enzyme(s). The
characterization of the AP1-dependent signaling pathway via specific
PKC isozymes will clarify the nature of the regulation, which will lead
us to the understanding of the molecular mechanisms of keratinocyte
differentiation.
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